commercialisation

Lots of creditable posts amongst the many rampings going on,

Something that most posters here seem to have forgotten or not read in PRR announcements (more than 1) is that commercialisation is expected to occur much sooner in other markets (Australia for 1) than in the US.

My interpretaion on these remarks and with current testing in Astralia under way is that CVAC could well be on the market late this year or early next year.

The income stream that this provides will certainly contribute to funding the US trials going forward.

I am in for the long run, hoping to lock down my position over the next few exciting and turbulant times.


These are simply my thoughts and opinions and as always do your own research and make your own decisions.